BAM Logo

Therapeutic drugs


EPTIS factsheet 411142 | Last revision 2017-09-15 | URL: https://www.eptis.bam.de/pts411142 https://www.eptis.bam.de/pts411142

PT provider
PT provider Labquality Labquality
Based in Finland
Language(s) English
Product groups Health care / medical devices
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human serum samples Amikasin, amitriptyline, carbamazepine free, cyclosporine, digoxin -
disopyramide, ethosuximide, flecainide, gentamycin, lidocaine, lithium, -
methotrexate, NAPA, netilmycin, nortriptyline, paracetamol (acetaminophen) -
phenobarbital, phenytoin, phenytoin free, primidone, procainamidem quinidine, salicylate, theophylline, tobramycin, -
tricyclics, valproic acid, valproic acid free, vancomycin -
Aims of the PT scheme
Target group of participants Laboratories/ Europe and Middle East
Linked to specific legislation / standards ISO15189
Additional, subsidiary aims
Number of participants 160
Accredited or otherwise reviewed by a 3rd party

Accredited by Finas (PT02) on the basis of ISO/EN 17043

Operation is commissioned / requested by
Fees and frequency
Participation fee Request a quotation: info@labquality.fi
Regularly operated Yes (4 rounds/year)
Year of first operation
Contact details of the PT provider
Provider Contact person
Kumpulantie 15
00520 Helsinki

Phone: +358 50 3742641
Fax: +358 9 8566 8280
Web: https://www.labquality.fi/en/eqas/ https://www.labquality.fi/en/eqas/
Mr Juha Wahlstedt
Phone: +358 50 3275338
Fax: +358 9 8566 8280
Email: juha.wahlstedt@labquality.fi juha.wahlstedt@labquality.fi
If you find any mistakes please contact the responsible EPTIS coordinator in Finland, Ms. Mirja Leivuori. Ms. Mirja Leivuori.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5